Evaluate OLMA stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in OLMA? | Glauxie AI

Q: What are the risks of investing in OLMA?

Olema Pharmaceuticals, Inc. (OLMA) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Sean Bohen. Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is... Employees: 10,000.

Q: How much debt does OLMA have?

Review OLMA total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is OLMA a good long-term investment?

Evaluate OLMA as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in OLMA?

🦉

Olema Pharmaceuticals, Inc. (OLMA)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOSean Bohen

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2...

Key Executives

Name	Title
Angelos Dovletoglou	Senior Vice President of CMC & Supply Chain
Courtney O'Konek	Vice President of Corporate Communications
David C. Myles	Chief Scientific Officer
Julie Dexter	Senior Vice President & Head of People
Kamesh Kuchimanchi	Senior Vice President of Regulatory Affairs & Quality Assurance
Mark Shilkrut	Senior Vice President of Clinical Development

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

OLMA Profile Financials

Is OLMA stock safe? How much debt does OLMA have? Is OLMA a good long-term investment?